ReNeuron Group Plc has appointed Bryan Geoffrey Morton as a non-executive director of the company with immediate effect. Mr Morton is chief executive officer of EUSA Pharma, Inc, a specialty pharmaceutical company he founded in 2006. The company has offices in the US and the UK. He is also a non-executive director of Protherics Plc, Aircraft Medical Ltd, a medical device company and is a member of the advisory board of Pilgrim Software.
Mr Morton began his pharmaceutical career in sales and then moved into a series of management positions including business development at Merck and Co Inc and Bristol Myers Squibb. In 2003, he founded Zeneus Pharma which was sold to Cephalon Inc in late 2005 for $360 million.
Copyright 2008 Evernow Publishing Ltd